Samal, Barmia A.
HRN: 24-68-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/09/2024
03/10/2024
IV
500mg
Q8 X 3 Doses
S/P Primary LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes